- Home
- LVO vs ASMB Comparison
LVO vs ASMB Comparison
Compare LVO & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVO
- ASMB
- Stock Information
- Founded
- LVO 2009
- ASMB 2005
- Country
- LVO United States
- ASMB United States
- Employees
- LVO N/A
- ASMB N/A
- Industry
- LVO Restaurants
- ASMB Biotechnology: Pharmaceutical Preparations
- Sector
- LVO Consumer Discretionary
- ASMB Health Care
- Exchange
- LVO Nasdaq
- ASMB Nasdaq
- Market Cap
- LVO 79.4M
- ASMB 84.5M
- IPO Year
- LVO N/A
- ASMB 2010
- Fundamental
- Price
- LVO $0.64
- ASMB $10.03
- Analyst Decision
- LVO Strong Buy
- ASMB Strong Buy
- Analyst Count
- LVO 2
- ASMB 3
- Target Price
- LVO $2.75
- ASMB $33.00
- AVG Volume (30 Days)
- LVO 330.5K
- ASMB 37.9K
- Earning Date
- LVO 05-29-2025
- ASMB 05-07-2025
- Dividend Yield
- LVO N/A
- ASMB N/A
- EPS Growth
- LVO N/A
- ASMB N/A
- EPS
- LVO N/A
- ASMB N/A
- Revenue
- LVO $126,016,000.00
- ASMB $28,520,000.00
- Revenue This Year
- LVO $0.69
- ASMB $10.82
- Revenue Next Year
- LVO N/A
- ASMB N/A
- P/E Ratio
- LVO N/A
- ASMB N/A
- Revenue Growth
- LVO 11.43
- ASMB 298.16
- 52 Week Low
- LVO $0.55
- ASMB $7.75
- 52 Week High
- LVO $1.99
- ASMB $19.93
- Technical
- Relative Strength Index (RSI)
- LVO 42.64
- ASMB 48.99
- Support Level
- LVO $0.62
- ASMB $7.90
- Resistance Level
- LVO $0.69
- ASMB $10.36
- Average True Range (ATR)
- LVO 0.07
- ASMB 0.85
- MACD
- LVO 0.00
- ASMB 0.21
- Stochastic Oscillator
- LVO 48.13
- ASMB 86.04
About LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.